MarĂa Molina: Understanding Early Phases of Respiratory Diseases at CIBER
On April 26, 2026, CIBER and Boehringer Ingelheim announced a strategic partnership to advance research into respiratory diseases, focusing on early-phase disease mechanisms in conditions such as chronic obstructive pulmonary ... Read More